These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1452444)

  • 1. Subtractive antibody to a human immunosuppressive lymphokine affinity isolates a suppressive factor and blocks its function.
    Haghighi AZ; Cathcart MK
    Immunopharmacology; 1992; 24(1):65-76. PubMed ID: 1452444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human hybridoma suppressor factor acts selectively on CD4+ cells.
    Tomita Y; Dustoor MM; Cathcart MK
    Immunopharmacology; 1988; 16(3):199-205. PubMed ID: 3267012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human hybridoma suppressor factor (HSF) inhibits IL2 production in addition to suppressing immunoglobulin production.
    Murakami M; Tomita Y; Cathcart MK
    Hybridoma; 1988 Dec; 7(6):595-608. PubMed ID: 3266185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective suppression of lymphokine production by human hybridoma suppressor factor (HSF).
    Tomita Y; Lieberman BY; Cathcart MK
    Immunobiology; 1990 Aug; 181(1):64-83. PubMed ID: 2125575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylation-inhibiting factor from human T cell hybridomas constructed from peripheral blood lymphocytes of a bee venom-sensitive allergic patient.
    Thomas P; Gomi H; Takeuchi T; Carini C; Tagaya Y; Ishizaka K
    J Immunol; 1992 Feb; 148(3):729-37. PubMed ID: 1730869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-binding glycosylation inhibiting factor from a human T-cell hybridoma specific for bee venom phospholipase A2.
    Gomi H; Tagaya Y; Nakano T; Mikayama T; Ishizaka K
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2824-8. PubMed ID: 7511819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody against human interleukin 2 (IL 2). I. Purification of IL 2 for the production of monoclonal antibodies.
    Stadler BM; Berenstein EH; Siraganian RP; Oppenheim JJ
    J Immunol; 1982 Apr; 128(4):1620-4. PubMed ID: 6977565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunosuppressive factors produced by T cell hybridoma.
    Tsunetsugu-Yokota Y; Honda M; Tokunaga T
    Hybridoma; 1989 Aug; 8(4):391-400. PubMed ID: 2789176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mechanisms of specific suppression of anti-hapten antibody response mediated by monoclonal anti-carrier antibody.
    Sumida T; Taniguchi M
    J Immunol; 1985 Jun; 134(6):3675-81. PubMed ID: 3157746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serologic, biologic and western blot analysis of human IgE-binding factor derived from a T cell hybridoma maintained in protein-free medium.
    Steele JK; Domingo R; Gomi H; Ishizaka K
    J Immunol; 1992 May; 148(9):2834-9. PubMed ID: 1573271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and characterization of monoclonal antibodies to embryo-associated immunosuppressor factor (EASF) produced by human pre-implantation embryo.
    Bose R; Nagy E; Fleetham J; Pattinson HA; Berczi I; Yang J
    Immunol Lett; 1993 Sep; 38(1):47-54. PubMed ID: 8300154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A "lymphokine-like" soluble product that induces proliferation and maturation of B cells appears in the serum-free supernatant of a T cell hybridoma as a consequence of mycoplasmal contamination.
    Proust JJ; Buchholz MA; Nordin AA
    J Immunol; 1985 Jan; 134(1):390-6. PubMed ID: 3871110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of a tumor-specific T suppressor factor from a T cell hybridoma.
    Steele JK; Stammers AT; Levy JG
    J Immunol; 1985 Apr; 134(4):2767-78. PubMed ID: 2579156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and partial amino acid sequence of suppressive lymphokine from a CD8+ CD57+ human T hybridoma.
    Quan CP; Watanabe S; Vuillier F; Pires R; Matsuo T; Stanislawski M; Pillot J; Bouvet JP
    Immunology; 1993 Feb; 78(2):205-9. PubMed ID: 7682534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of an antigen-specific T cell subset that forms IgE-suppressive factor and IgG-suppressive factor on antigenic stimulation.
    Jardieu P; Uede T; Ishizaka K
    J Immunol; 1985 Aug; 135(2):922-9. PubMed ID: 2409160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of a human nonspecific suppressor factor from ascitic fluid of systemic lupus erythematosus. Evidence for a human counterpart of the monoclonal nonspecific suppressor factor and relationship to the T cell receptor alpha-chain.
    Xavier RM; Nakamura M; Tsunematsu T
    J Immunol; 1994 Mar; 152(5):2624-32. PubMed ID: 8133068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody specific for T cell-derived human IgE binding factors.
    Kisaki T; Huff TF; Conrad DH; Yodoi J; Ishizaka K
    J Immunol; 1987 May; 138(10):3345-51. PubMed ID: 2437189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics.
    Smith KA; Favata MF; Oroszlan S
    J Immunol; 1983 Oct; 131(4):1808-15. PubMed ID: 6352804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of glycosylation-inhibiting factor with plasma membranes of T suppressor cell hybridomas.
    Iwata M; Katamura K; Mori A; Yamagushi K; Grey H; Ishizaka K
    J Immunol; 1990 Dec; 145(11):3578-88. PubMed ID: 2147196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification, characterization and anti-tumor activity of a new cytokine, histiocyte-secreted-factor (HSF).
    Satomi N; Haranaka R; Haranaka K
    Int J Cancer; 1996 Apr; 66(2):209-13. PubMed ID: 8603813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.